Validation of a Prognostic Score for Good Visual Recovery at One Year Following Combined Surgery for Cataract and Idiopathic Epiretinal Membrane

Launched by CENTRE HOSPITALIER UNIVERSITAIRE DIJON · Oct 31, 2017

Keywords

ClinConnect Summary

This clinical trial is investigating a new scoring system designed to help predict how well patients will recover their vision one year after undergoing combined surgery for cataracts and a condition called idiopathic epiretinal membrane (ERM). ERM can cause vision problems, especially in people over 50, and while many cases are mild, surgery is often needed to improve vision and quality of life. The study aims to confirm findings from previous research that identified specific factors—like age, how long symptoms have been present, and the initial level of vision—that can help doctors determine the chances of a good recovery.

To participate in this trial, patients must be at least 40 years old and have a visible ERM that is affecting their vision. Those who have other eye conditions or have previously had certain surgeries may not be eligible. If you join the trial, you can expect to undergo the combined surgery and will have your progress monitored over the year to see how well the new scoring system works. This study could lead to better guidelines for when to perform ERM surgery, ultimately helping more patients achieve better vision outcomes.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients presenting idiopathic ERM visible on SD-OCT;
• • Indication for combined cataract and ERM surgery in a context of a fall in visual acuity or disabling metamorphopsia;
• • Patients who have provided verbal consent;
• • Age ≥ 40 years.
• Exclusion Criteria:
• • Patients with secondary ERM (Diabetes WITH a history of diabetic retinopathy or maculopathy, occlusion of the retinal veins, uveitis intermediate/posterior uveitis or retinal tear/detachment in the studied eye;
• • Patient présentant toute autre maculopathie ou neuropathie optique ;
• • Patient presenting severe myopia (spherical equivalent ≥ 6 diopters or axial length ≥ 26 mm) ;
• • Patients presenting any other ophthalmological disease independent of the ERM and likely to limit visual acuity
• • Patients who have already undergone vitrectomy in the studied eye;
• • Non-visible or poorly visible fundus due to a cloudy vitreous (Signal on OCT Cirrus \<5, Quality score on OCT Spectralis \< 20, signal trend index on OCT Optovue \< 30)
• • Patients without national health insurance cover
• • Pregnant or breast-feeding women.